CannabisNewsBreaks

ThursdayMar 29, 2018 3:38 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Anticipates Additional Technology Licensing Contracts in 2018

Lexaria Bioscience’s (CSE: LXX) (OTCQB: LXRP) CEO Chris Bunka recently discussed the company’s plans regarding technology licensing contracts in an audio interview. An article further discussing the company reads: “LXRP is a British Columbia, Canada-based bioscience company that is a drug delivery platform innovator. The company has developed its patented DehydraTECH™ delivery technology platform, which it out-licenses to promote healthier ingestion methods and lower overall dosing. …Bunka said that LXRP believes that 6-12 more licensing contracts will be signed this year, both generating more revenue for the company and building greater shareholder value. “We’ve only just graduated from the demonstration…

Continue Reading

ThursdayMar 29, 2018 10:05 am

CannabisNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Announces Arrival of First Cannabis Shipment at University of Queensland

Health sciences company PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) this morning announced the arrival of the first shipment of dried cannabis flower and oils from Aurora Cannabis Inc. (TSX: ACB) (OTCQB: ACBFF) at the University of Queensland’s Pharmacy Australia Centre of Excellence. Per the news release, testing of the imported cannabis strains in the application of PreveCeutical’s Sol-gel drug delivery technology is now expected to commence. The impending Sol-gel program aims to develop a system that will increase the bioavailability of drugs through the use of an innovative nose-to-brain delivery platform. The company notes that Sol-gels could…

Continue Reading

WednesdayMar 28, 2018 9:41 am

CannabisNewsBreaks – Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) Enters LOI to Acquire Flower Power Cannabis Pharms Inc.

British Columbia-based cannabis cultivation firm Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) this morning announced its entry into a letter of intent to acquire Flower Power Cannabis Pharms Inc., a retail brand experience cannabis company, as well as its wholly-owned subsidiary, High Way 10 Cannabis Pharms Inc. Per the update, High Way 10, located in southern Saskatchewan, is currently in the active review stage of Health Canada’s application process under the ACMPR, and its initial 16,000 sq. ft. facility is capable of producing roughly 1,500 kg of dried cannabis per annum. “We are very pleased Choom™ has increased its total…

Continue Reading

MondayMar 26, 2018 3:35 pm

CannabisNewsBreaks – Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) Prepares to Pounce on Canada’s Recreational Cannabis Market Following Upcoming Legalization

British Columbia-based cannabis cultivation firm Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF) is currently planning its expansion strategy as the end of cannabis prohibition in Canada approaches. An article discussing the company reads: “According to the company’s investor presentation made in November, by 2021, the recreational marijuana industry that Choom™ Holdings exclusively aims to serve is expected to be almost eight times the size of the medical marijuana industry, which is served by Choom’s Medi-Can Health Solutions Ltd. subsidiary, with benefits spilling over into the tourism industry, governmental tax and licensing coffers, and paraphernalia manufacturing market. Its nimble business model…

Continue Reading

MondayMar 26, 2018 3:24 pm

CannabisNewsBreaks – Namaste Technologies, Inc. (CSE: N) (FRA: M5BQ) (OTC: NXTTF) Subsidiary Inks Medical Cannabis Supply Agreement with Clever Leaves

Namaste Technologies (CSE: N) (FRA: M5BQ) (OTC: NXTTF), through its wholly-owned subsidiary Cannmart Inc., has signed a medical cannabis product acquisition agreement with medical cannabis producer Clever Leaves with the assistance of Clever Leaves’ financial sponsor, Northern Swan Holdings, Inc. Clever Leaves is a vertically integrated, licensed producer of medical cannabis in Colombia that recently commenced construction of a 15+ hectare good agricultural collection practices compliant cultivation facility and Good Manufacturing Practices (“GMP”) Level-2 Extraction facility. Per the terms of the agreement, Cannmart will submit purchase orders to Clever Leaves for medical cannabis. Subject to approval by Health Canada, Cannmart…

Continue Reading

MondayMar 26, 2018 9:28 am

CannabisNewsBreaks – Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Completes Integration of California Subsidiary

Vancouver-based biopharmaceutical company Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) this morning announced that it has successfully completed the integration of its California subsidiary, ERS Holdings Ltd., under the guidance of Patrick Rolfes, president of Pivot Pharmaceuticals USA. Per the update, Pivot is currently preparing for a 2018 product launch in California, with a consumer-facing brand scheduled to be unveiled in the coming weeks. “As the Company prepares for legalization of cannabis in Canada, we continue to expand our business operations in the US market on a state-by-state basis, where regulations permit,” Dr. Patrick Frankham, Pivot CEO, stated…

Continue Reading

FridayMar 23, 2018 3:47 pm

CannabisNewsBreaks – Isodiol International Inc. (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F) Inks Partnership Agreement with Kawacatoose First Nation

Isodiol International (CSE: ISOL) (OTC: ISOLF) (FSE: LB6A.F), a global Bioactive CBD innovator specializing in the development of pharmaceutical and wellness products, recently announced that it has signed a partnership agreement with Kawacatoose First Nation (“KFN”). The two companies will collaborate to cultivate and manufacture high yielding CBD derived from industrial hemp. The companies also intend to explore additional economic opportunities in commercializing the hemp by-product into everyday finished goods. Per the terms of the agreement, KFN will provide up to 3,000 farmable acres of land, based on availability and subject to certain conditions being met by both parties on…

Continue Reading

FridayMar 23, 2018 12:16 pm

CannabisNewsBreaks – Global Hemp Group, Inc. (CSE: GHG) (FRA: GHG) (OTC: GBHPF) Capitalizing on the Vast Market Potential of Hemp, CBD Products

Hemp cultivation company Global Hemp Group (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF) remains primarily focused on the cultivation of hemp and cannabinoid extraction for both domestic and international markets. An article discussing the company reads: “Founded in 2014, Global Hemp Group is building a strategic portfolio of hemp-based companies to provide its global customer base with a consistent supply of high-quality hemp-derived products. It intends to leverage the huge market potential of hemp products to deliver significant ROI to its shareholders. The number of products that can be manufactured from the hemp plant is vast. It can be used to…

Continue Reading

FridayMar 23, 2018 11:22 am

CannabisNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Technology Mimics the Body’s Natural Creation of Pain Fighting Peptides

Health sciences company PreveCeutical Medical (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) is engaged in the development of pain relievers that mimic body’s natural pain relief peptides. An article discussing the company reads: “The linker technology that underlies PreveCeutical’s drug development platform was developed at the University of Queensland in Australia. At that impressive institution, Dr. Parekh headed a team that developed synthetic molecules capable of mimicking the endomorphins produced by the body for pain relief, as explained by PreveCeutical chairman and CEO Stephen Van Deventer in a recent video interview (http://cnw.fm/fEO5a). Although they are as potent as morphine, the effect…

Continue Reading

ThursdayMar 22, 2018 12:34 pm

CannabisNewsBreaks – Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) Leverages Opportunity in Cannabis Industry through Strategic, Diversified Investments

Liberty Leaf Holdings (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) offers investors a unique option for diversified exposure across the entire legal cannabis market. An article discussing the company reads: “Liberty Leaf takes calculated and strategic investment positions in established, proven performers in both the medicinal and recreational legal cannabis markets. Liberty Leaf targets and then acquires and/or partners with established, revenue-producing marijuana businesses that have large upside potential. Liberty’s objective is to build a substantial, broad-based portfolio of multiple cannabis-sector businesses, including companies across the full spectrum of activities, from the cultivation and processing of legal medicinal and recreational cannabis…

Continue Reading